1. Zamora D. Women's top 5 health concerns: From heart disease to breast cancer to depression, WebMD gives you the inside info on why women are at high risk for these problems but may not know it. Atlanta, GA: WebMD, LLC;2010. Cited by 2015 Feb 2. Available from:
http://www.webmd.com/women/features/5-top-female-healthconcern.
2. Kim A, Lee JH, Lee JY, Oh YM, Hong SN, Choi H, et al. Association between serum homocysteine concentrations and bone mineral density in middle aged women. J Korean Soc Menopause. 2013; 19:81–86.
3. Chung HW, Kang BM, Kim MR, Yoon BK, Lee BS, Choi H, et al. The influence of thyroid function on bone mineral density in Korean postmenopausal women. J Korean Soc Menopause. 2012; 18:36–42.
4. Kim TH, Lee HH, Chung SH, Park HS. Differentiation in the management of osteoporosis between premenopausal and menopausal women. J Korean Soc Menopause. 2011; 17:21–26.
5. Hwang SY, Kim TH, Lee HH. Neutral sphingomyelinase and breast cancer research. J Menopausal Med. 2015; 21:24–27.
6. Gulick RM. Current status of new antiretroviral drugs in development. Top Antivir Med. 2002; 10:14–19.
7. O'Brien RJ, Spigelman M. New drugs for tuberculosis: current status and future prospects. Clin Chest Med. 2005; 26:327–340.
8. Pharmaceutical research and manufacturers of America. Medicines in development diabetes. Biopharmaceutical research companies are developing 180 medicines to treat diabetes and related conditions. Washington, DC: Pharmaceutical Research and Manufacturers of America;2014. Cited by 2015 Apr 1. Available from:
http://www.phrma.org/sites/default/files/pdf/diabetes2014.pdf.
9. Malla S, Hobbs JE, Sogah EK, Yeung MT. Assessing the functional foods and natural health products industry: A comparative overview and literature review. Can Agric Innov Regul Netw. 2013; 32:1–6.
10. International Trade Centre. The North American market for natural products: prospects for Andean and African products. Geneva, CH: International Trade Centre;2012.
11. Huang X, Kong L, Li X, Chen X, Guo M, Zou H. Strategy for analysis and screening of bioactive compounds in traditional Chinese medicines. J Chromatogr B Analyt Technol Biomed Life Sci. 2004; 812:71–84.
12. Lee SW, You YO. Bioidentical hormone therapy in post-menopausal women. J Korean Soc Menopause. 2010; 16:6–15.
13. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, et al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 2012; 40:D1100–D1107.
14. Korea Bio-Economy Research Center. 2014 Biopharmaceutics trend report. Seongnam: Korea Bio-Economy Research Center;2014.
15. Yoon DH, Kwon OY, Mang JY, Jung MJ, Kim do Y, Park YK, et al. Protective potential of resveratrol against oxidative stress and apoptosis in Batten disease lymphoblast cells. Biochem Biophys Res Commun. 2011; 414:49–52.
16. Chan MM. Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin. Biochem Pharmacol. 2002; 63:99–104.
17. Frémont L. Biological effects of resveratrol. Life Sci. 2000; 66:663–673.
18. Filip V, Plocková M, Šmidrkal J, Špičková Z, Melzoch K, Schmidt Š. Resveratrol and its antioxidant and antimicrobial effectiveness. Food Chem. 2003; 83:585–593.
19. Rotondo S, Rajtar G, Manarini S, Celardo A, Rotillo D, de Gaetano G, et al. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol. 1998; 123:1691–1699.
20. de la Lastra CA, Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans. 2007; 35:1156–1160.
21. Tomé-Carneiro J, Gonzálvez M, Larrosa M, Yáñez-Gascón MJ, García-Almagro FJ, Ruiz-Ros JA, et al. Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective. Ann N Y Acad Sci. 2013; 1290:37–51.
22. Carter LG, D'Orazio JA, Pearson KJ. Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer. 2014; 21:R209–R225.
23. Potterat O. Goji (Lycium barbarum and L. chinense): Phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity. Planta Med. 2010; 76:7–19.
24. Li XM, Li XL, Zhou AG. Evaluation of antioxidant activity of the polysaccharides extracted from Lycium barbarum fruits in vitro. Eur Polym J. 2007; 43:488–497.
25. Luo Q, Cai Y, Yan J, Sun M, Corke H. Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci. 2004; 76:137–149.
26. Ming M, Guanhua L, Zhanhai Y, Guang C, Xuan Z. Effect of the Lycium barbarum polysaccharides administration on blood lipid metabolism and oxidative stress of mice fed high-fat diet in vivo. Food Chem. 2009; 113:872–877.
27. Zhu M, Jinggang M, ChangSheng H, Haiping X, Ning M, Caijiao W. Extraction, characterization of polysaccharides from lycium barbarum and its effect on bone gene expression in rats. Carbohydr Polym. 2010; 80:672–676.
28. Li X, Yuan FL, Zhao YQ, Chen FH, Lu WG, Li CW, et al. Effects of leonurine hydrochloride on medically induced incomplete abortion in early pregnancy rats. Eur J Obstet Gynecol Reprod Biol. 2011; 159:375–380.
29. Pang S, Tsuchiya S, Horie S, Uchida M, Murayama T, Watanabe K. Enhancement of phenylephrine-induced contraction in the isolated rat aorta with endothelium by H2O-extract from an Oriental medicinal plant Leonuri herba. Jpn J Pharmacol. 2001; 86:215–222.
30. Tao J, Zhang P, Liu G, Yan H, Bu X, Ma Z, et al. Cytotoxicity of Chinese motherwort (YiMuCao) aqueous ethanol extract is non-apoptotic and estrogen receptor independent on human breast cancer cells. J Ethnopharmacol. 2009; 122:234–239.
31. Liang H, Liu P, Wang Y, Song S, Ji A. Protective effects of alkaloid extract from Leonurus heterophyllus on cerebral ischemia reperfusion injury by middle cerebral ischemic injury (MCAO) in rats. Phytomedicine. 2011; 18:811–818.
32. Schmidt S, Jakab M, Jav S, Streif D, Pitschmann A, Zehl M, et al. Extracts from Leonurus sibiricus L. increase insulin secretion and proliferation of rat INS-1E insulinoma cells. J Ethnopharmacol. 2013; 150:85–94.
33. Hasrat JA, De Bruyne T, De Backer JP, Vauquelin G, Vlietinck AJ. Isoquinoline derivatives isolated from the fruit of Annona muricata as 5-HTergic 5-HT1A receptor agonists in rats: unexploited antidepressive (lead) products. J Pharm Pharmacol. 1997; 49:1145–1149.
34. García-Conesa M, Estrada-Reyes R, Araujo Escalona , Ledesma Velázquez I, Martínez-Mota L, Moreno J, et al. Antidepressant-like effects of an alkaloid extract of the aerial parts of Annona cherimolia in mice. J Ethnopharmacol. 2012; 139:164–170.
35. Cheng TF, Jia XM, Ma XH, Lin HP, Zhao YH. Phylogenetic study on Shiraia bambusicola by rDNA sequence analyses. J Basic Microbiol. 2004; 44:339–350.
36. Tong Y, Zhang X, Zhao W, Zhang Y, Lang J, Shi Y, et al. Anti-angiogenic effects of Shiraiachrome A, a compound isolated from a Chinese folk medicine used to treat rheumatoid arthritis. Eur J Pharmacol. 2004; 494:101–109.